A carregar...

Niacin plus Simvastatin Reduces Coronary Stenosis Progression Among Patients with Metabolic Syndrome Despite a Modest Increase in Insulin Resistance: A Subgroup Analysis of the HDL-Atherosclerosis Treatment Study (HATS)

BACKGROUND: Metabolic syndrome, insulin resistance and diabetes are associated with an increased risk of cardiovascular disease. Niacin is known to increase insulin resistance, and have adverse effects on blood glucose levels, but to have beneficial effects on plasma lipids and lipoproteins. We ther...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vittone, Francesca, Chait, Alan, Morse, Josh S., Fish, Brian, Brown, B. Greg, Zhao, Xue-Qiao
Formato: Artigo
Idioma:Inglês
Publicado em: 2007
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2157569/
https://ncbi.nlm.nih.gov/pubmed/18591993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacl.2007.05.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!